Kevin B. Kim

Biochemistry, Genetics and Molecular BiologyMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

1in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Papers

Driven by 11 papers. Top paper: “Phase Ib/II Trial of Ribociclib in Combination with Binimetinib in Patients with NRAS -mutant Melanoma”.

Phase Ib/II Trial of Ribociclib in Combination with Binimetinib in Patients with NRAS -mutant Melanoma

Clinical Cancer Research(2022)10.1158/1078-0432.ccr-21-3872

N/A

1.6DataRank · unranked

44 citations

Lisa Zimmer, Kevin B. Kim, Jeffrey A. Sosman, Paolo A. Ascierto, Michael A. Postow +10 more

Activity of dasatinib against L576P KIT mutant melanoma: Molecular, cellular, and clinical correlates

Molecular Cancer Therapeutics(2009)10.1158/1535-7163.mct-09-0459

N/A

0.777DataRank · unranked

177 citations

Jonathan C. Trent, Katherine Stemke-Hale, Alexander J. Lazar, Sabrina Pricl, Giovanni M. Pavan +11 more

Combined programmed cell death protein 1 and cytotoxic T-lymphocyte associated protein 4 blockade in an international cohort of patients with acral lentiginous melanoma

British Journal of Dermatology(2024)10.1093/bjd/ljae401

N/A

0.312DataRank · unranked

7 citations

Karam Ashouri, Eftychia Chatziioannou, Jesús Antonio Ocejo Gallegos, Jabra Zarka, Jacob Kechter +39 more

Data from Nuclear Receptor Coactivator NCOA3 Regulates UV Radiation–Induced DNA Damage and Melanoma Susceptibility

(2023)10.1158/0008-5472.c.6513430.v1

N/A

0DataRank · unranked

0 citations

Vladimir Bezrookove, Mehdi Nosrati, Altaf A. Dar, James R. Miller, Stanley P. L. Leong +10 more

Immune profiling of uveal melanoma identifies a potential signature associated with response to immunotherapy

Journal for ImmunoTherapy of Cancer(2020)10.1136/jitc-2020-000960

N/A

0DataRank · unranked

61 citations

Kathryn Bollin, Mariana Petaccia de Macêdo, Fernando C. L. Carapeto, Kevin B. Kim, Jason Roszik +12 more

Data from Activity of dasatinib against L576P KIT mutant melanoma: Molecular, cellular, and clinical correlates

(2023)10.1158/1535-7163.c.6531608.v1

N/A

0DataRank · unranked

0 citations

Jonathan C. Trent, Katherine Stemke‐Hale, Alexander J. Lazar, Sabrina Pricl, Giovanni M. Pavan +11 more

Genomic copy-number variants drive apoptotic evasion underlying acquired resistance to immune checkpoint inhibitors

Immunity(2025)10.1016/j.immuni.2025.10.001

N/A

0DataRank · unranked

3 citations

Shiyue Yang, Zhentao Yang, Jianfeng Fan, Shirley H. Lomeli, Prashanthi Dharanipragada +12 more

Combinatorial therapy regimens targeting preclinical models of melanoma resistant to immune checkpoint blockade

Journal of Clinical Investigation(2025)10.1172/jci185220

N/A

0DataRank · unranked

0 citations

Aida Rodriguez-Brotons, Anukana Bhattacharjee, Vladimir Bezrookove, Altaf A. Dar, David de Semir +15 more

Data from Activity of dasatinib against L576P KIT mutant melanoma: Molecular, cellular, and clinical correlates

(2023)10.1158/1535-7163.c.6531608

N/A

0DataRank · unranked

0 citations

Jonathan C. Trent, Katherine Stemke‐Hale, Alexander J. Lazar, Sabrina Pricl, Giovanni M. Pavan +11 more

Nuclear Receptor Coactivator NCOA3 Regulates UV Radiation–Induced DNA Damage and Melanoma Susceptibility

Cancer Research(2021)10.1158/0008-5472.can-20-3450

N/A

0DataRank · unranked

19 citations

Vladimir Bezrookove, Mehdi Nosrati, Altaf A. Dar, James R. Miller, Stanley P. L. Leong +10 more

Data from Phase Ib/II Trial of Ribociclib in Combination with Binimetinib in Patients with NRAS-mutant Melanoma

(2023)10.1158/1078-0432.c.6532311

N/A

0DataRank · unranked

0 citations

Lisa Zimmer, Kevin B. Kim, Jeffrey A. Sosman, Paolo A. Ascierto, Michael A. Postow +10 more